Home > Boards > US Listed > Medical - Equipment > Helius Medical Technologies Inc. (HSDT)

The company recently announced another clinic that will

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
tykundegex Member Profile
 
Followed By 41
Posts 3,727
Boards Moderated 0
Alias Born 08/18/09
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 3:31:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/3/2021 10:53:13 AM
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021 GlobeNewswire Inc. - 2/2/2021 7:30:00 AM
Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-A... GlobeNewswire Inc. - 2/1/2021 5:15:00 PM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 1/29/2021 6:13:24 AM
Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market GlobeNewswire Inc. - 1/28/2021 8:30:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/20/2021 1:15:16 PM
Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medi... GlobeNewswire Inc. - 1/20/2021 7:05:00 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 1/20/2021 6:07:47 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/19/2021 7:16:01 AM
Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards GlobeNewswire Inc. - 1/19/2021 7:05:00 AM
Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference GlobeNewswire Inc. - 1/15/2021 12:37:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/11/2021 7:16:13 AM
Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS... GlobeNewswire Inc. - 1/11/2021 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/5/2021 4:12:40 PM
Helius Medical Technologies, Inc. Comments on Unusual Market Activity GlobeNewswire Inc. - 1/5/2021 4:05:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/5/2021 12:19:13 PM
Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January GlobeNewswire Inc. - 1/4/2021 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/31/2020 7:21:05 AM
Helius Medical Technologies, Inc. Announces Reverse Stock Split GlobeNewswire Inc. - 12/31/2020 7:05:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 12/30/2020 6:05:42 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 12/21/2020 5:24:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2020 4:22:37 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 12/16/2020 4:19:04 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 12/10/2020 4:32:19 PM
tykundegex   Monday, 02/17/20 03:15:18 AM
Re: None
Post # of 174 
The company recently announced another clinic that will offer PoNS treatment, bringing the total to 8 in Canada, slightly ahead of the number they anticipated to have by the end of 2019. However, the latest clinic is a one-physician outfit, 40 miles from the largest city on Vancouver island, with a population of under 100,000 people, so it's hardly a "material event" worthy of an 8K.

If the patient outcomes from the initial larger clinics are as good as the company has been touting, the PT community will surely pick up on it and more clinics will sign-on. If they fail to get the word out and build momentum by the end of summer 2020, then I'm inclined to think it's not going happen. And if there is no commercial traction in Canada, then a US FDA approval would be a non-event.

If, on the other hand, we do get strong testimonials from patients and physicians, and the company can get their devices into more Canadian clinics, it would bode well for the stock (finally) and FDA approval would be an inflection point.

For now, I'm watching this space with a speculative position (well into the red), and ready to invest more should we see encouraging progress.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences